Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PCV13 infant immunization schedule comparison study
NL-OMON26136Active, not recruiting
- Sponsor
- National Institute for Public Health and the Environment
- Start
- May 2010
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Open-label trial of pneumococcal 13-valent conjugate vaccine in pneumococcal disease (4 arms), sponsored by National Institute for Public Health and the Environment. Primary endpoint: Primary immunogenicity endpoint. Started May 2010; status: active, not recruiting.
02
Drugs
pneumococcal 13-valent conjugate vaccine
03
Conditions
pneumococcal disease
Beyond the preview
Go deeper on NL-OMON26136.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON26136.